^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Mantle Cell Lymphoma |
| Regimen: | R-Maxi-CHOP |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
05/11/2023
Excerpt:
Mantle Cell Lymphoma….Preferred regimens...NORDIC regimen: Dose-intensified induction immunochemotherapy with rituximab + cyclophosphamide, vincristine, doxorubicin, prednisone (maxi-CHOP) alternating with rituximab + high-dose cytarabine
